Increased ACSL4 expression is a determinant of drug resistance in metastatic breast cancer cells where altered cellular energetics leads to increased expression of the ATP-binding cassette (ABC) transporter, which mediates the egress of chemotherapeutic molecules [35]. This evidence concerns the gene ACSL4 and breast cancer.